SCHEMBL7669079

SCHEMBL7669079

O=C(NCCc1ccccc1)[C@H]1CC[C@H](Nc2nc3ccccc3[nH]2)CC1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 3/20 0.57
▸ POLB P06746 3/20 0.52
▸ NPC1 O15118 2/20 0.52
▸ RAB9A P51151 2/20 0.52
▸ TDP1 Q9NUW8 1/20 0.52
▸ NPSR1 Q6W5P4 1/20 0.52
▸ GAA P10253 1/20 0.51
▸ LMNA P02545 1/20 0.50
▸ MAPT P10636 1/20 0.50
▸ KCNH2 Q12809 2/20 0.48
▸ TP53 P04637 1/20 0.48
▸ RXFP1 Q9HBX9 1/20 0.48
▸ ALDH1A1 P00352 3/20 0.47
▸ TSHR P16473 1/20 0.47
▸ L3MBTL1 Q9Y468 1/20 0.47
▸ KDM4E B2RXH2 1/20 0.47
▸ MAPK1 P28482 1/20 0.47
▸ HSD17B10 Q99714 1/20 0.47
▸ MEN1 O00255 1/20 0.46
▸ KMT2A Q03164 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7085647 0.89 SMN1; SMN2 (0.59) SMN1; SMN2POLBNPC1RAB9ATDP1
SCHEMBL7089468 0.89 SMN1; SMN2 (0.59) SMN1; SMN2POLBNPC1RAB9ATDP1
SCHEMBL7085654 0.89 SMN1; SMN2 (0.59) SMN1; SMN2POLBNPC1RAB9ATDP1
SCHEMBL7697532 0.85 MAPK1 (0.54) SMN1; SMN2POLBNPC1RAB9ATDP1
SCHEMBL7691415 0.83 SMN1; SMN2 (0.55) SMN1; SMN2POLBNPC1RAB9ATDP1
SCHEMBL7694028 0.83 SMN1; SMN2 (0.55) SMN1; SMN2POLBNPC1RAB9ATDP1
SCHEMBL7694033 0.83 SMN1; SMN2 (0.55) SMN1; SMN2POLBNPC1RAB9ATDP1
SCHEMBL7082045 0.81 SMN1; SMN2 (0.63) SMN1; SMN2POLBNPC1RAB9ATDP1
SCHEMBL7544328 0.81 SMN1; SMN2 (0.63) SMN1; SMN2POLBNPC1RAB9ATDP1
SCHEMBL7172907 0.81 SMN1; SMN2 (0.63) SMN1; SMN2POLBNPC1RAB9ATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6291499-B1 TREATING MIGRAINE, DEPRESSION, ANXIETY, SCHIZOPHRENIA, PARKINSON'S DISEASE, OR STROKE MERCK & CO., INC. 2001-09-18 — — US claimed
US-6495561-B2 TREATING MIGRAINE, DEPRESSION, ANXIETY, SCHIZOPHRENIA, PARKINSON'S DISEASE, OR STROKE MERCK & CO., INC. 2002-12-17 — — US disclosed
US-6380205-B1 QUINAZOLINE THROUGH A C1-C4ALKYL, C1- C4ALKENYL, C1-C4ALKYNYL, C1-C4ALKOXY, AMINO, AMINOC1-C4ALKYL, HYDROXYC1-C4ALKYL, CARBONYL, CYCLOC3-C6ALKYL OR AMINOCARBONYL CHAIN, USEFUL FOR TREATMENT OF THE PAIN MERCK & CO., INC. 2002-04-30 — — US disclosed
US-6291499-B1 TREATING MIGRAINE, DEPRESSION, ANXIETY, SCHIZOPHRENIA, PARKINSON'S DISEASE, OR STROKE MERCK & CO., INC. 2001-09-18 — — US disclosed
Send feedback